| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.01 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |